Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) SIG Poster Highlight

Nov 07 2025
Convention Center: Science in the Park - Site A - Level 3
12:45 PM - 1:15 PM

World Class Speakers

Ludovic Saba, MD, MSc
Presenter

Ludovic Saba, MD, MSc

UT Southwestern Medical Center
Nikhil Kalita, MPH
Presenter

Nikhil Kalita, MPH

UCSD MASLD Research Center
Carolin Lackner, M D
Presenter

Carolin Lackner, M D
Pinelopi Manousou, Medical degree
Moderator

Pinelopi Manousou, Medical degree

Imperial College Healthcare NHS Trust
Rashmee Patil, MD
Moderator

Rashmee Patil, MD

Pinnacle Clinical Research

Description

Join us for a poster highlight of the top abstracts from the MASLD SIG. 
 

Journey Maps

Presentations

12:45 PM - 12:48 PM
Nov 07 2025
Washington, D.C.

Welcome & Introductions

Pinelopi Manousou, Medical degree, Moderator
MASLD
12:48 PM - 12:53 PM
Nov 07 2025
Washington, D.C.

Empagliflozin Reduces Incident Cirrhosis, Hepatic Decompensation, and Mortality in MASLD/MASH Patients with Diabetes: A Propensity-Matched Analysis of A Multi-institutional EHR Database

Ludovic Saba, MD, MSc, Presenter
MASLD
12:53 PM - 12:58 PM
Nov 07 2025
Washington, D.C.

Validation of New Clinical Obesity Criteria for Steatotic Liver Disease in the United States

Nikhil Kalita, MPH, Presenter
MASLD
12:58 PM - 1:03 PM
Nov 07 2025
Washington, D.C.

Comparison of digital images versus glass slides for the histopathological evaluation of liver biopsy samples according to the NASH-CRN scoring system for MASH: A validation performed as part of the NATiV3 study

Carolin Lackner, M D, Presenter
MASLD
1:03 PM - 1:15 PM
Nov 07 2025
Washington, D.C.

Q&A/Panel Discussion/Closing

Rashmee Patil, MD, Moderator
MASLD